Target intelligence / Profile preview

Cellular membranes and biomolecular interfaces

Molecular classification
Lipid bilayer, Biological interface, Cellular structure
01

Overview

Cellular membranes and biomolecular interfaces are fundamental biological structures composed of lipid bilayers, proteins, and carbohydrates that delineate the boundaries of cells and organelles (Source: Molecular Biology of the Cell, Alberts B. et al.). They function as selective barriers, regulating the transport of ions and molecules, and serve as critical platforms for signal transduction and energy conversion (Source: Nature Reviews Molecular Cell Biology). While not a single molecular entity, these interfaces are recognized as therapeutic targets for various agents, particularly in the treatment of infectious diseases where drugs like daptomycin and amphotericin B disrupt the integrity of microbial membranes (Source: PubMed, PMID: 25131140). Furthermore, the physical properties of these interfaces, such as fluidity and surface tension, are modulated by lung surfactants and certain anesthetics to achieve clinical effects (Source: StatPearls, Lung Surfactant). In pathological states like cancer and neurodegeneration, changes in membrane composition and lipid peroxidation at the interface play significant roles in disease progression (Source: Journal of Lipid Research). Consequently, targeting the unique biophysical properties of these interfaces remains a specialized strategy in drug development, though it presents challenges regarding systemic toxicity and cellular specificity (Source: NIH, National Institute of General Medical Sciences).

Other names
Cell membranePlasma membraneLipid bilayerBiological interfaceBiomembraneCellular interface
02

Mechanism of action

Membrane disruption, pore formation, alteration of membrane fluidity, and modulation of surface tension.

03

Biological functions

CompartmentalizationSignal transductionMolecular transportCell-cell recognitionEnergy transduction
04

Disease associations

InfectionCancerNeurodegenerative diseaseCardiovascular disease
05

Safety considerations

Lack of cellular specificityHemolysisSystemic toxicity (e.g., nephrotoxicity)Off-target effects on host cell membranes
06

Interacting drugs

Daptomycin

6 more in the full profile.

07

Biomarkers

Phosphatidylserine exposure (Annexin V binding)Lipid peroxidation products (e.g., malondialdehyde)Membrane fluidity index

Beyond the preview

Go deeper on Cellular membranes and biomolecular interfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membranes and biomolecular interfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call